Learning Objectives:

• Understanding the clinimetric requirements for robust outcome measures in CIPN clinical trials
• Becoming familiar with the most robust clinical outcome measures for CIPN
• Understanding the minimum requirements to shape preclinical models whose data can be promptly translated to bed-side
• Being able to weight the robustness of preclinical studies and therefore the biological rationale to be then transferred to clinical trials

Agenda: 

• Introduction - Dr. Andreas Argyriou & Dr. Paola Alberti (Chairs)
• Clinical CIPN Outcome Measures - Prof. Ingemar Merkies
• Preclinical CIPN Outcome Measures (Rodent Models) - Prof. Guido Cavaletti

 This webinar was hosted by the Neurological Complications Study Group